Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05001347
Title A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ) in Patients With Ovarian Cancer and Selected Solid Tumors
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors I-Mab Biopharma US Limited
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.